Toll-like receptors in health and disease: Complex questions remain

被引:168
作者
Sabroe, I [1 ]
Read, RC
Whyte, MKB
Dockrell, DH
Vogel, SN
Dower, SK
机构
[1] Univ Sheffield, Royal Hallamshire Hosp, Div Genomic Med, Sheffield S10 2JF, S Yorkshire, England
[2] Univ Maryland, Dept Microbiol & Immunol, Baltimore, MD 21702 USA
关键词
D O I
10.4049/jimmunol.171.4.1630
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1630 / 1635
页数:6
相关论文
共 83 条
[61]   Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells [J].
Re, F ;
Strominger, JL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (40) :37692-37699
[62]   A functional polymorphism of Toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease [J].
Read, RC ;
Pullin, J ;
Gregory, S ;
Borrow, R ;
Kaczmarski, EB ;
di Giovine, FS ;
Dower, SK ;
Cannings, C ;
Wilson, AG .
JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (05) :640-642
[63]   Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFκB and expression of the inducible cyclooxygenase [J].
Rhee, SH ;
Hwang, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (44) :34035-34040
[64]   Selective roles for toll-like receptor (TLR)2 and TLR4 in the regulation of neutrophil activation and life span [J].
Sabroe, I ;
Prince, LR ;
Jones, EC ;
Horsburgh, MJ ;
Foster, SJ ;
Vogel, SN ;
Dower, SK ;
Whyte, MKB .
JOURNAL OF IMMUNOLOGY, 2003, 170 (10) :5268-5275
[65]   Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: A critical role for monocytes in leukocyte lipopolysaccharide responses [J].
Sabroe, I ;
Jones, EC ;
Usher, LR ;
Whyte, MKB ;
Dower, SK .
JOURNAL OF IMMUNOLOGY, 2002, 168 (09) :4701-4710
[66]   Impaired IFN-γ production in IFN regulatory factor-1 knockout mice during endotoxemia is secondary to a loss of both IL-12 and IL-12 receptor expression [J].
Salkowski, CA ;
Thomas, KE ;
Cody, MJ ;
Vogel, SN .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3970-3977
[67]   Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression [J].
Sing, A ;
Rost, D ;
Tvardovskaia, N ;
Roggenkamp, A ;
Wiedemann, A ;
Kirschning, CJ ;
Aepfelbacher, M ;
Heesemann, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (08) :1017-1024
[68]   Identification of two major sites in the type I interleukin-1 receptor cytoplasmic region responsible for coupling to pro-inflammatory signaling pathways [J].
Slack, JL ;
Schooley, K ;
Bonnert, TP ;
Mitcham, JL ;
Qwarnstrom, EE ;
Sims, JE ;
Dower, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (07) :4670-4678
[69]   Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility [J].
Smirnova, I ;
Mann, N ;
Dols, A ;
Derkx, HH ;
Hibberd, ML ;
Levin, M ;
Beutler, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (10) :6075-6080
[70]   Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential [J].
Stanley, MA .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2002, 27 (07) :571-577